1.
Liang J-H, Wang L, Zhu H-Y, Qian J, Liao H, Wu J-Z, Xia Y, Wu W, Cao L, Fan L, Li J-Y, Xu W. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica [Internet]. 2020Jan.1 [cited 2026Nov.5];105(1):e29-e32. Available from: https://haematologica.org/article/view/9501